Continuous Hemofiltration During Cardiopulmonary Bypass and Its Effect on Lactatemia

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

January 30, 2018

Study Completion Date

February 28, 2018

Conditions
Cardiovascular Diseases
Interventions
PROCEDURE

Polysulfone Filter

The intervention for this group consisted using a Polysulfone filter in order to hemofiltration in the procedure involving Cardiopulmonary Bypass (CPB).The perfusionist's role is essential during the procedure, as they control both Cardiac Output (CO) and gas exchange, depending on their action, will affect blood lactate levels.

PROCEDURE

Procedure/ Surgery: without Polysulfone Filter

In this group, no intervention is performed during the procedure involving Cardiopulmonary Bypass (CPB)

Trial Locations (1)

11009

Hospital Puerta del Mar, Cadiz

All Listed Sponsors
collaborator

Mª José Abellán Hervás

UNKNOWN

collaborator

Rocío Martín Valero

UNKNOWN

collaborator

Ana María Sáinz Otero

UNKNOWN

lead

University of Cadiz

OTHER

NCT03412968 - Continuous Hemofiltration During Cardiopulmonary Bypass and Its Effect on Lactatemia | Biotech Hunter | Biotech Hunter